Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;34(2):202-212.
doi: 10.1111/fcp.12521. Epub 2019 Dec 11.

Cancer stem cells as therapeutic targets of pancreatic cancer

Ebrahim Razi  1 , Mehran Radak  2 , Maryam Mahjoubin-Tehran  3   4 , Samaneh Talebi  5 , Alimohammad Shafiee  6 , Sarah Hajighadimi  6 , Sanaz Moradizarmehri  6 , Hossein Sharifi  1 , Nousin Mousavi  7 , Mostafa Sarvizadeh  1 , Majid Nejati  8 , Mohsen Taghizadeh  9 , Faezeh Ghasemi  10
Affiliations
Review

Cancer stem cells as therapeutic targets of pancreatic cancer

Ebrahim Razi et al. Fundam Clin Pharmacol. 2020 Apr.

Abstract

The discovery of stem cells and their potential abilities in self-renewal and differentiation has opened a new horizon in medicine. Scientists have found a small population of stem cells in some types of cancers with the same functions as normal stem cells. There are two models for tumor progression: clonal (stochastic) and cancer stem cell (CSCs) models. According to the first model, all transformed cells in the tumor have carcinogenic potential and are able to proliferate and produce the same cells. The latter model, which has received more attention recently, considers the role of CSCs in drug resistance and tumor metastasis. Following the model, researchers have found that targeting CSCs may be a promising way in cancer therapy. This review describes CSC characteristics in general, while also focusing on CSC properties in the context of pancreatic cancer.

Keywords: cancer stem cell; pancreatic cancer; therapeutic targets.

PubMed Disclaimer

Comment in

References

    1. Pourhanifeh M.H., Mohammadi R., Noruzi S. et al. The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy. Cancer Cell Int. (2019) 19 157. https://doi.org/10.1186/s12935-019-0870-6
    1. Mirzaei H.R., Pourghadamyari H., Rahmati M. et al. Gene-knocked out chimeric antigen receptor (CAR) T cells: tuning up for the next generation cancer immunotherapy. Cancer Lett. (2018) 423 95-104.
    1. Mohammadi M., Jaafari M.R., Mirzaei H.R., Mirzaei H. Mesenchymal stem cell: a new horizon in cancer gene therapy. Cancer Gene Ther. (2016) 23 285-286.
    1. Saadatpour Z., Rezaei A., Ebrahimnejad H. et al. Imaging techniques: new avenues in cancer gene and cell therapy. Cancer Gene Ther. (2017) 24 1-5.
    1. Saadatpour Z., Bjorklund G., Chirumbolo S. et al. Molecular imaging and cancer gene therapy. Cancer Gene Ther. (2016). https://doi.org/10.1038/cgt.2016.62. in press

MeSH terms

LinkOut - more resources